Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7934 results

Sort By:

Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Study ID: NCT06790966
Start Date: 2025-04
End Date: 2029-02
Study Type

Interventional

Study Phase

Phase3

No. of Participants

351

Intervention / Treatment

Combination Treatment of PDS0101 and Pembrolizumab

Pembrolizumab Monotherapy

Sponsor

PDS Biotechnology Corp.

Source: clinicaltrials.gov

Share:
Add to list

A Clinical Trial Evaluating TG4050 in Head and Neck Cancer

Study ID: NCT04183166
Start Date: 2019-12-12
End Date: 2028-12-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

80

Intervention / Treatment

TG4050

Sponsor

Transgene

Source: clinicaltrials.gov

Share:
Add to list

Augmented Whole-body Scanning Via Magnifying PET/CT (AWSM-PET/CT) Techniques Abilities to Improve Upon the Diagnostic Accuracy of the Standard-of-care (SOC) PET/CT for Malignant Lesion Detection

Study ID: NCT05513027
Start Date: 2024-03-06
End Date: 2027-05-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

35

Intervention / Treatment

Augmented Whole-body Scanning via Magnifying PET

PET/CT

Sponsor

Washington University School of Medicine

Source: clinicaltrials.gov

Share:
Add to list

Comparing Supplemental Topical Agents for the Treatment of Acute Radiation Dermatitis in Patients With Breast Cancer

Study ID: NCT05340673
Start Date: 2022-06-21
End Date: 2025-12-21
Study Type

Interventional

Study Phase

Phase1

No. of Participants

200

Intervention / Treatment

Agent Affecting Integumentary System

Petrolatum-Mineral Oil-Lanolin-Ceresin Ointment

Quality-of-Life Assessment

Administration questionnaire

Sponsor

City of Hope Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Telehealth Self-Management Coaching Sessions to Improve Quality of Life in Pancreatic Cancer Survivors and Their Family Care Givers

Study ID: NCT06524973
Start Date: 2024-10-07
End Date: 2027-05-03
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

136

Intervention / Treatment

Telemedicine

Counseling

Best Practice

Administration questionnaire

Inrweview

Sponsor

City of Hope Medical Center

Source: clinicaltrials.gov

Share:
Add to list

GammaPod Registry and Quality of Life Nomogram

Study ID: NCT03562273
Start Date: 2019-01-03
End Date: 2027-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

160

Intervention / Treatment

Quality Of Life Sizing Nomogram

Sponsor

University of Maryland, Baltimore

Source: clinicaltrials.gov

Share:
Add to list

Prescription of Letrozole for Uterine Myoma

Study ID: NCT06143631
Start Date: 2024-07-24
End Date: 2027-04-30
Study Type

Interventional

Study Phase

Phase4

No. of Participants

140

Intervention / Treatment

Letrozole 2.5mg

Placebo

Sponsor

University of California, San Francisco

Source: clinicaltrials.gov

Share:
Add to list

A Study of Amivantamab in People with Esophagogastric Cancer

Study ID: NCT05117931
Start Date: 2021-12-02
End Date: 2025-11
Study Type

Interventional

Study Phase

Phase2

No. of Participants

25

Intervention / Treatment

Amivantamab

Sponsor

Memorial Sloan Kettering Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Seleno-Lionin (SLM)-Axitinib-Pemmbrolizumabababababol.

Study ID: NCT05363631
Start Date: 2022-09-19
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

55

Intervention / Treatment

Selenomethionine (SLM)

Sarcasm

Pembrolizumab

Sponsor

Mohammed Milhem

Source: clinicaltrials.gov

Share:
Add to list

A Behavioral Intervention to Promote Primary Prevention and Uterine Preservation in Premenopausal Women With Obesity and Endometrial Hyperplasia

Study ID: NCT05903131
Start Date: 2024-10-24
End Date: 2029-10-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

96

Intervention / Treatment

Telemedicine behavioral weight intervention

Progestin

Enhanced usual care

Levonorgestrel-releasing IUD.

Sponsor

Washington University School of Medicine

Source: clinicaltrials.gov

Share:
Add to list